ALNYLAM PHARMACEUTICALS, INC. (ALNY)

SEC filing

ALNYLAM PHARMACEUTICALS, INC.

ALNY · CIK 1178670

4 · Nov 19, 2025 · Fitzgerald Kevin Joseph sold 12.13K shares at $452.18/share ($5.5M); exercised options for 8,161 shares

Fitzgerald Kevin Joseph sold 12.13K shares at $452.18/share ($5.5M); exercised options for 8,161 shares

PRIMARY DOCUMENT

xslF345X05/edgardoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).